RESEARCH ALLIANCE CORP III RACC
ORD SHS CL A · Common Stock · CUSIP G75226103
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersNew York, NY
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $10.71.
Biggest buyers
| PERCEPTIVE ADVISORS LLC | New | +750.0k |
| ADAR1 Capital Management, LLC | New | +650.0k |
| BVF INC/IL | New | +500.0k |
| Spruce Street Capital LP | New | +500.0k |
| Balyasny Asset Management L.P. | New | +500.0k |
| Commodore Capital LP | New | +500.0k |
| Trails Edge Capital Partners, LP | New | +500.0k |
| TCG Crossover Management, LLC | New | +500.0k |
| BRAIDWELL LP | New | +400.0k |
| Affinity Asset Advisors, LLC | New | +370.0k |
Biggest sellers
| None |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Research Alliance Holdings III LLC /Cayman
13D · may seek influence
+2.2 pts · filed 2026-07-28
Stated purposeItem 4 of the Statement is hereby amended and supplemented as follows: Business Combination Agreement On July 26, 2026, the Issuer, OHB Pediatrics Ltd., a company incorporated under the laws of England and Wales (the "Company"), and the shareholders of the Company (the "Shareholders"), entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the "Business Combination Agreement"), pursuant to which, among other things and subject to the terms and conditions contained therein, the Issuer will acquire 100% of the outstanding shares in the capital of the Company from the Shareholders in exchange for newly issued shares of the RACC Common Stock (as defined below) (the "Share Acquisition"). The transactions contemplated by the B… Full filing |
16.9% |
| Nantahala Capital Management, LLC 13G · institution new · filed 2026-10-07 | 14.1% |
| ADAR1 Capital Management, LLC 13G · institution new · filed 2026-08-14 | 8.4% |
| PERCEPTIVE ADVISORS LLC 13G · passive investor new · filed 2026-05-28 | 8.2% |
| GREAT POINT PARTNERS LLC 13G · passive investor new · filed 2026-09-11 | 6.5% |
| BALYASNY ASSET MANAGEMENT L.P. 13G · institution new · filed 2026-08-14 | 6.4% |
| TCG Crossover GP III, LLC 13G · passive investor new · filed 2026-08-14 | 6.4% |
| Spruce Street Capital LP 13G · institution new · filed 2026-08-13 | 6.4% |
| BIOTECHNOLOGY VALUE FUND L P 13G · passive investor new · filed 2026-05-29 | 6.4% |
| Trails Edge Capital Partners, LP 13G · passive investor new · filed 2026-05-29 | 5.5% |
| Commodore Capital LP 13G · passive investor new · filed 2026-05-28 | 5.5% |
Fell to 5% or below in the last year: BANK OF AMERICA CORP /DE/ (0.0%, 2026-10-28)
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| PERCEPTIVE ADVISORS LLC 0.12% of their portfolio | 750.0k $8.0m | New |
| ADAR1 Capital Management, LLC 0.33% of their portfolio | 650.0k $7.0m | New |
| BVF INC/IL 0.14% of their portfolio | 500.0k $5.3m | New |
| Balyasny Asset Management L.P. 0.01% of their portfolio | 500.0k $5.3m | New |
| Commodore Capital LP 0.32% of their portfolio | 500.0k $5.3m | New |
| TCG Crossover Management, LLC 0.13% of their portfolio | 500.0k $5.3m | New |
| Spruce Street Capital LP 1.05% of their portfolio | 500.0k $5.3m | New |
| Trails Edge Capital Partners, LP 0.85% of their portfolio | 500.0k $5.3m | New |
| BRAIDWELL LP 0.16% of their portfolio | 400.0k $4.3m | New |
| Jupiter Topco LLC 0.00% of their portfolio | 400.0k $4.4m | First filing |
| Cormorant Asset Management, LP 0.20% of their portfolio | 370.0k $4.0m | New |
| Affinity Asset Advisors, LLC 0.19% of their portfolio | 370.0k $4.0m | New |
| SILVERARC CAPITAL MANAGEMENT, LLC 0.43% of their portfolio | 360.0k $3.9m | New |
| Venrock Adviser, LLC 0.10% of their portfolio | 300.0k $3.2m | New |
| Foresite Capital Management VI LLC 0.50% of their portfolio | 300.0k $3.2m | New |
| J. Goldman & Co LP 0.07% of their portfolio | 177.5k $1.9m | New |
| TORONTO DOMINION BANK 0.00% of their portfolio | 146.8k $1.6m | New |
| Logos Global Management LP 0.05% of their portfolio | 100.0k $1.1m | New |
| ARISTEIA CAPITAL, L.L.C. 0.01% of their portfolio | 50.0k $535.0k | New |
| TWO SIGMA INVESTMENTS, LP 0.00% of their portfolio | 33.9k $362.9k | New |
| Lineage Point Capital LP 0.05% of their portfolio | 23.3k $249.3k | New |
| UBS Group AG 0.00% of their portfolio | 16 $171 | New |
| MORGAN STANLEY 0.00% of their portfolio | 7 $75 | New |